A 96-well equilibrium dialysis block was designed and constructed that is compatible with most standard 96-well format laboratory supplies and instruments. The unique design of the dialysis apparatus allows one to dispense and aspirate from either or both the sample and dialysate sides from the top
Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding
โ Scribed by Nigel J. Waters; Rachel Jones; Gareth Williams; Bindi Sohal
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 225 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
โฆ Synopsis
Equilibrium dialysis (ED) is one of the most frequently used approaches to investigate drug binding, where the major drawbacks are the time to reach equilibrium (varying between 6 and 24 h), a long assay preparation time and complexity of automation. A rapid equilibrium dialysis (RED) device has recently become commercially available (Pierce Biotechnology, ThermoFisher Scientific, Waltham, MA) offering the potential for reduced preparation and equilibration times. The RED device comprises a Teflon base plate which holds up to 48 disposable dialysis cells. Each dialysis insert is made up of two side-by-side chambers separated by a vertical cylinder of dialysis membrane with a high membrane surface area-to-volume ratio. An independent validation of the RED approach for the measurement of human plasma protein binding (PPB) was carried out as a comparative analysis with standard ED evaluating equilibration time, assay reproducibility and accuracy and ease of use. Using a diverse set of 18 commercially available drugs spanning a range of physicochemical properties we have shown this to be a robust and accurate methodology, with a shorter preparation and dialysis time, capable of being automated as a high-throughput assay for the determination of PPB.
๐ SIMILAR VOLUMES
noted that the parameter values reported by Kearns and Wilson were derived from a one-dog study. No literature information regarding the pharmacokinetics of I in nephrectomized dogs is available. In this study, serum concentrations of I in nephrectomized dogs were lower than the corresponding conce
Definitive plasma protein binding (PB) studies in drug development are routinely conducted with radiolabeled material, where the radiochemical purity limits quantitative PB measurement. Recent and emerging regulatory guidances increasingly expect quantitative determination of the fraction unbound (F
## Abstract Various factors influencing the protein binding of DAโ8159 to 4% human serum albumin (HSA) were evaluated using an equilibrium dialysis technique at an initial DAโ8159 concentration of 5 ยตg/mL. It took approximately 8 h incubation to reach an equilibrium between 4% HSA and an isotonic p